Aqsitania SAS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Aqsitania SAS - overview
Established
2014
Location
-, -, France
Primary Industry
Medical Devices & Equipment
About
Based in France, and founded in 2014, Aqsitania SAS is a company that specializes in the respiratory telemonitoring of chronically ill patients and professional athletes. As of April 2023, the company is led by its CEO Patrick Hanusse. Aqsitania SAS provides anharmonic morphological analysis of respiratory signals (AMASR) technology to cater to the telemonitoring of chronically ill patients and professional athletes. The company's ventilatometry technology allows for the definition of respiratory function and establishes the patient's respiratory status through the Personal Respiratory Profile® (PRP).
Additionally, the technology allows for secure monitoring of chronic respiratory patients at home and a signal analysis service to study and extract relevant information. The company is also involved in providing project construction and management services for analysis projects, respecting its scope of intervention and good business practices.
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment, Monitoring Equipment, Analytics & Performance Software, Medical Software
Website
www.aqsitania.com
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.